USPTO serial 79448312
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine F. Hoffman
Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell & Berkowitz, PC200 East Broward Blvd, Suite 2000Ft. Lauderdale, FL 33301United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biological and molecular genetic products intended for laboratory analysis, industry and science; bioactive reagents and compounds; peptides, peptide derivatives, proteins, glycans, nucleotides, lipids, antibodies, antibody-active principle conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; chemical, biochemical, biological, biotechnological and molecular genetic preparations for industrial and scientific use; chemical, biological, biotechnological and molecular genetic preparations, namely polypeptides and proteins for reagent development or production for industrial and scientific applications; biological preparations, namely polypeptides, peptide derivatives or proteins for laboratories and analysis for industrial and scientific applications; chemical and biochemical substances for use in the manufacture of pharmaceuticals. | ACTIVE | — |
| 005 | Pharmaceutical products, medical preparations; pharmaceuticals and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates; chemical, biological, molecular genetic and biochemical and biopharmaceutical products for medical, pharmaceutical use, namely peptides, peptide derivatives, proteins, antibodies, active antibody conjugates, antibody fragments, antibody derivatives, nucleic acids, DNA, vectors; pharmaceutical products and substances for the treatment of diseases and preparations for medical treatments. | ACTIVE | — |
| 035 | Providing information with respect to business contacts for research projects. | ACTIVE | — |
| 042 | Scientific and technological services as well as research work and design services relating thereto, namely, services provided by scientists dedicated to the chemical and technological study of biological molecules; scientific, medical, biological, molecular genetic, chemical, pharmaceutical and technological research, in the field of biochemistry or pharmacy; services of a biochemical or pharmaceutical laboratory; industrial analysis and research services; development and experimentation of medicines; conducting preclinical and clinical trials; laboratory services for the benefit of third parties; scientific advisory services in the biochemical, biological and molecular genetic fields; scientific advice for the pharmaceutical industry sector; analysis services for medical and pharmaceutical research services in connection with the treatment of individuals, included in class 42; provision of scientific research information and results. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 28, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 28, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 25, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 11, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 11, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 28, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 22, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 22, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |